Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement. - Test2 - elhamkhani - TriplyDB

Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

http://www.wikidata.org/entity/Q35098186

about

Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum.Novel RpoS-Dependent Mechanisms Strengthen the Envelope Permeability Barrier during Stationary Phase.Anti-virulence Strategies to Target Bacterial Infections.Sleeper cells: the stringent response and persistence in the Borreliella (Borrelia) burgdorferi enzootic cycle.In Vitro Emergence of High Persistence upon Periodic Aminoglycoside Challenge in the ESKAPE Pathogens Edwardsiella tarda Sip2: A Serum-Induced Protein That Is Essential to Serum Survival, Acid Resistance, Intracellular Replication, and Host Infection.Estimating treatment prolongation for persistent infections

P2860

Q26775404-D16515D1-26E8-4051-BF5A-366F1E28CD16 Q36137993-8EBCFC49-773B-4ECD-BAE1-E36BAB9114D0 Q37543423-90D6F1F7-6D7D-41D7-9EC0-D013DF1243A0 Q38760476-29DE0206-3696-4105-96F6-9BAEDB0E4938 Q40081460-8A33E8C9-64F3-4618-B49F-40C13CC60127 Q40672200-A8AACA03-1961-4FF0-8C28-3B8ACCA680E1 Q55038532-80214F89-DB30-4DD7-A51A-649606147837 Q58792186-6ABECA45-3218-44A3-8116-BA24311C3236

P2860

Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.

http://www.wikidata.org/entity/Q35098186

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Phenotypic heterogeneity enabl ...... ibiotics and serum complement.

@ast

Phenotypic heterogeneity enabl ...... ibiotics and serum complement.

@en

type

label

Phenotypic heterogeneity enabl ...... ibiotics and serum complement.

@ast

Phenotypic heterogeneity enabl ...... ibiotics and serum complement.

@en

prefLabel

Phenotypic heterogeneity enabl ...... ibiotics and serum complement.

@ast

Phenotypic heterogeneity enabl ...... ibiotics and serum complement.

@en

P1433

Q35098186-77B47499-51B4-46F5-9251-B471E1BE0336

P1476

Q35098186-63674975-8170-4CA0-8492-BA915E9DA5BF

P2093

Q35098186-3617E41E-2586-4260-938A-6FCC8A02B875

Q35098186-5698DB69-C639-45E7-B05A-996301C8673C

Q35098186-9539734E-10CA-4617-B760-FF737D6537D7

Q35098186-DC554C5F-686C-42D0-A925-578B7F189903

Q35098186-F359A25D-CB18-46E2-B4D5-8192D022A4C1

P2860

Q35098186-068FCE67-48A0-4191-956F-F9354FE91C30

Q35098186-0745172B-1A81-44FD-8E45-58F25055C92E

Q35098186-1049BAC8-7C4B-43FC-B450-8EE13907E6C9

Q35098186-13EB1C16-5969-4E2E-801F-7A4148904DE4

Q35098186-15E10959-B4A5-479E-84FC-D1A907D860C7

Q35098186-178A42B5-0627-49EA-B175-D0E82F414373

Q35098186-19137C8F-0536-4283-9AC8-11D92289979D

Q35098186-1F6272EB-D442-44B0-B30D-C261EA122BD1

Q35098186-2151C7B9-FA6E-456F-A742-BC4FDFD6755F

Q35098186-2A0852AD-036D-4F15-8A4B-319221DA17F1

P304

Q35098186-849CB21B-EF59-4957-9F5C-DD62FA41A07E

P31

Q35098186-4DF8046D-DA6F-4E45-A701-87FDB98B3D96

P356

Q35098186-E3A2EFFE-3F88-4EF4-B246-571F96769168

P407

Q35098186-AF553C1F-D698-4B66-B786-D770620AFF03

P433

Q35098186-D8631A23-CEA3-49A8-8BA7-DC1F1E22AE1F

P478

Q35098186-1369DF1B-B310-43A1-90FC-0C11300549A1

P50

Q35098186-DDB24A90-C85A-47A0-AEF4-F1ADC65143F6

P577

Q35098186-925E2F5A-230B-4717-A4C7-737062C4E300

P698

Q35098186-68448086-7D51-4AC7-AA20-AC8025EF3B71

P921

Q35098186-3B78B718-947D-4ABC-A7D0-5E70614463F3

P932

Q35098186-5FB5B009-6121-45C9-99F4-ADE37F740ACD

P356

P1433

Infection and Immunity

P1476

Phenotypic heterogeneity enabl ...... ibiotics and serum complement.

@en

P2093

Eliisa Lukk

http://www.w3.org/2001/XMLSchema#string

Karin Kogermann

http://www.w3.org/2001/XMLSchema#string

Markus Lippus

http://www.w3.org/2001/XMLSchema#string

Marta Putrinš

http://www.w3.org/2001/XMLSchema#string

Vallo Varik

http://www.w3.org/2001/XMLSchema#string

P2860

Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.

Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software

Metabolite-enabled eradication of bacterial persisters by aminoglycosides

hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis

The cost of virulence: retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

Determination of minimum inhibitory concentrations

Bacterial persistence as a phenotypic switch

Persister cells

Translation initiation region sequence preferences in Escherichia coli.

P304

1056-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.02725-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25561706

http://www.w3.org/2001/XMLSchema#string

P921

P932

4333455

http://www.w3.org/2001/XMLSchema#string